A vaccine strategy with multiple prostatic acid phosphatase-fused cytokines for prostate cancer treatment

Immunotherapy is one of the attractive treatment strategies for advanced prostate cancer. The US Food and Drug Administration (FDA) previously approved the therapeutic vaccine, sipuleucel-T, which is composed of autologous antigen-presenting cells cultured with a fusion protein [prostatic acid phosp...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncol Rep
Huvudupphovsmän: FUJIO, KEI, WATANABE, MASAMI, UEKI, HIDEO, LI, SHUN-AI, KINOSHITA, RIE, OCHIAI, KAZUHIKO, FUTAMI, JUNICHIRO, WATANABE, TOYOHIKO, NASU, YASUTOMO, KUMON, HIROMI
Materialtyp: Artigo
Språk:Inglês
Publicerad: D.A. Spandidos 2015
Ämnen:
Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4358080/
https://ncbi.nlm.nih.gov/pubmed/25632844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2015.3770
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk